Clinical Trials

Find a Trial

Trial Summary

Protocol No.10PLK13
StatusOPEN TO ACCRUAL
Principal InvestigatorLogan, Theodore
ScopeNational
PhaseNA
Age GroupAdult
TitleProleukin? Observational Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
DescriptionThe purpose of this study is to collect information on patients who are receiving treatment with Proleukin in an organized way to learn more about patient care during and after treatment.
Key EligibilityIn order to be eligible to take part in this trial, patients must meet the following criteria:

  • Must have received at least one course of high dose IL-2 or Proleukin
  • 18 years or older
For a full list of participation criteria, please visit: clinicaltrials.gov.
Applicable Disease SitesKidney (Renal Cell) Cancer
Melanoma
Participating InstitutionsIndiana University (IU)
  • Indiana University Hospital / IU Simon Cancer Center
Treatment TypeRegistry